Esorix-L Capsule SR is a combination medication containing Levosulpiride 75mg and Esomeprazole 40mg, formulated to provide effective relief from gastrointestinal disorders. Levosulpiride, a prokinetic and antipsychotic agent, enhances gastrointestinal motility by blocking dopamine receptors, thereby improving gastric emptying and alleviating symptoms such as nausea, vomiting, bloating, and abdominal discomfort associated with functional dyspepsia and gastroparesis. Esomeprazole, a proton pump inhibitor, reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the stomach lining, promoting healing of acid-related damage such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The sustained-release formulation ensures prolonged therapeutic action, improving patient compliance by reducing dosing frequency. Esorix-L Capsule SR is indicated for the management of acid peptic disorders accompanied by motility disturbances, providing symptomatic relief and mucosal protection. It should be used under medical supervision, especially in patients with liver impairment or those on concomitant medications that may interact with proton pump inhibitors or dopamine antagonists. Common side effects may include headache, dizziness, dry mouth, and mild gastrointestinal disturbances. Patients are advised to report any adverse reactions promptly to their healthcare provider.

Dosage & How to Use